IGF-I as a nutritional marker;IGF-I, marqueur nutritionnel

Nutrition Clinique et Metabolisme

Volumn 10, Issue 4 SUPPL., 1996, Pages 265-274

  Jeevanandam, Malayappa ^a  

^a ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

GH IGF I IGFBP 3 axis; IGF I; Nutrient intake

Indexed keywords

ANABOLIC AGENT; SOMATOMEDIN C;

FOOD INTAKE; HUMAN; NUTRITION; REVIEW;

EID: 0030464073     PISSN: 09850562     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0985-0562(96)80005-7     Document Type: Article

References (83)

1. Bistrian BR, Blackburn GL, Hallowell E, Heddle R. Protein status of general surgical patients. JAMA 1974 ; 230 : 858-60.
2. Weinsier RL, Hunker EM, Krumdieck CL, Butterworth CE. Hospital malnutrition: a prospective evaluation of general medical patients during the course of hospitalization. Am J Clin Nutr 1979 ; 32 : 418-29.
3. Grant JB, Custer PB, Thrulow J. Current techniques of nutritional assessment. Surg Clin North Am 1981 ; 61 : 437-63.
4. Unterman TG, Vazquez RM, Slas AJ, Martyn PA, Phillips LS. Nutrition and somatomedin XIII. Usefulness of somatomedin-C in nutritional assessment. Am J Med 1985 ; 78 : 228-34.
5. Copeland KC, Underwood LE, Van Wyk JJ. Induction of immunoreactive somatomedin-C in human serum by growth hormone: dose response relationship and effect on chromatographic profiles. J Clin Endocrinol Metab 1980 ; 50 : 690-7.
6. Isley WL, Underwood LE, Clemmons DR. Dietary components that regulate serum somatomedin-C concentrations in humans. J Clin Invest 1983 ; 71 : 175-82.
7. Hintz RL, Suskind R, Amatayakul K, Thanagkul O, Olsm R. Plasma somatomedin and growth hormone values in children with protein-calorie malnutrition. J Pediat 1978 ; 92 : 152-6.
8. Jeevanandam M, Holaday NJ, Shamos RF, Petersen SR. Acute IGF-I deficiency in multiple trauma victims. Clin Nutr 1992 ; 11 : 352-7.
9. Hawker FH, Stewart PM, Baxter RC, Borkmann M, Tan K, Caterson ID et al. Relationship of somatomedin-C/insulin-like growth factor-I levels to conventional nutritional indices in critically ill patients. Crit Care Med 1987 ; 15 : 732-6.
10. Donahue SP, Phillips LS. Responses of IGF-I to nutritional support in malnourished hospital patients: a possible indicator of short-term changes in nutritional status. Am J Clin Nutr 1989 ; 50 : 962-9.
11. Clemmons DR, Klibanski D, Underwood LE, McAuthur JW, Ridgway EC, Van Wyk JJ. Reduction of plasma immunoreactive somatomedin-C during fasting in humans. J Clin Endocrinol Metab 1981 ; 51 : 1247-51.
12. Merimee TJ, Zapf J, Froesh ER. Insulin-like growth factors in the fed and fasted states. J Clin Endocrinol Metab 1992 ; 55 : 999-1002.
13. Phillips LS, Orawski AT, Belosky DC. Somatomedin and nutrition. IV Regulation of somatomedin activity and growth cartilage activity by quantitation and composition of diet in rats. Endocrinology 1978 ; 103 : 121-7.
14. Reeves RD, Dickinson L, Lee J, Kilgore B, Branham B, Elders MJ. Effect of dietary composition on somatomedin activity in growing rats. J Nutr 1979 ; 109 : 613-20.
15. Thissen J-P, Ketelslegers J-M, Underwood LE. Nutritional regulation of insulin-like growth factors. Endocrine Rev 1994 ; 15 : 80-101.
16. Ling PR, Grollaher C, Colon E, Istfan N, Bistrian BR. IGF-I alters energy expenditure and protein metabolism during parenteral feeding in rats. Am J Clin Nutr 1995 ; 61 : 116-20.
17. Miller LL, Schalch DS, Draznin B. Role of the liver in regulating somatomedin activity: effects of streptozotocin diabetes and starvation on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated perfused rat liver. Endocrinology 1981 ; 108 : 1265-71.
18. Schwander JC, Hauri C, Zapt J, Froesch ER. Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinology 1983 ; 113 : 297-305.
19. Furlanetto RW, Underwood LE, Van Wyk JJ, D'Ercole AJ. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radio immunoassay. J Clin Invest 1977 ; 60 : 648-57.
20. D'Ercole AJ, Stiles AD, Underwood LE. Tissue concentrations of somatomedin-C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci USA 1984 ; 81 : 935-9.
21. Underwood LE, D'Ercole AJ, Clemmons DR, Van Wyk JJ. Paracrine functions of somatomedin. Clin Endocrinol Metab 1986 ; 15 : 59-77.
22. Holly JMP, Wass JAH. Insulin-like growth factors: autocrine, paracrine, or endocrine? New prospects of the somatomedin hypothesis in the light of recent developments. J Endocrinol 1989 ; 122 : 611-8.
23. Salmon WD, Daughaday WH. A hormonally-controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 1957 ; 49 : 825-36.
24. Martin JL, Baxter BC. Insulin-like growth factor binding protein-3 : Biochemistry and physiology. Growth Regul 1992 ; 2 : 88-99.
25. Guyda HJ. Concepts of IGF Physiology. In : Spencer EM editor. Modern Concepts of insulin-like growth factors. New York : Elsevier Science, 1991 : 99-109.
26. Grant DB, Hambley J, Becker D, Pimstone BL. Reduced sulphation factor in undernourished children. Arch Dis Child 1973 ; 48 : 596-600.
27. Ho KY, Veldhius JD, Johnson ML, Furlanetto R, Evans WS, Alberti KGMM et al. Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest 1988 ; 81 : 968-75.
28. 3 patterns during fasting in obese subjects. Clin Endocrinol 1984 ; 20 : 65-70.
29. Maes M, Underwood LE, Ketelslegers JM. Plasma somatomedin-C in fasted and refed rats: Close relationship with changes in liver somatogenic (GH) but not lactogenic (PRC) binding sites. J Endocrinol 1983 ; 97 : 243-52.
30. Jeevanandam M, Holaday NJ, Petersen SR. Plasma levels of insulin-like-growth factor binding protein-3 in acute trauma patients. Metabolism 1995 ; 44 : 1205-8.
31. Petersen SR, Jeevanandam M, Holaday NJ. Adjuvant recombinant human growth hormone stimulates insulin-like-growth factor binding protein 3 secretion in critically ill trauma patients. J Trauma 1995 ; 39 : 295-302
32. Mohan PS, Jaya Rao KS. Plasma somatomedin activity in protein-calorie malnutrition. Arch Dis Child 1979 ; 54 : 62-4.
33. Smith IF, Latham MC, Azabuika JA, Butler WR, Phillips LS, Pong WG et al. Blood plasma levels of cortisol, insulin growth hormone and somatomedin in children with kwashiorkor and intermediate forms of protein-energy malnutrition. Proc Soc Expt Biol Med 1981 ; 167 : 607-11.
34. Smith SR, Edgar PJ, Pozefsky T, Chhetri MK, Prout TE. Growth hormone in adults with protein calorie malnutrition. Endocrinology 1974 ; 39 : 53-62.
35. Soliman AT, Hassen AEI, Aref MK, Hintz RL, Rosenfeld RG, Rogol AD. Serum insulin-like growth factor I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-calorie malnutrition before and after nutritional rehabilitation. Pediatr Res 1986 ; 20 : 1122-30.
36. Phillips LS. Nutrition, somatomedins and the brain. Metabolism 1986 ; 35 : 78-87.
37. Rappaport R, Prevot C, Czernichow P. Somatomedin activity and growth hormone secretion. I. Changes related to body weight in anorexia nervosa. Acta Paediatr Scand 1980 ; 69 : 37-41.
38. Counts DR, Gwirtsman H, Carlsson LMS, Lesem M, Cutler GB. The effects of anorexia nervosa and refeeding on growth-hormone binding protein, insulin-like growth factors (IGFs), and the IGF binding proteins. J Clin Endocrinol Metab 1992 ; 75 : 762-7.
39. Lecornu M, David L, Francois R. Low serum somatomedin activity in celiac disease. Helv Paediatr Acta 1978 ; 33 : 509-16.
40. Kirschner BS, Sutton MM. Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease. Gastroenterology 1986 ; 91 : 830-6.
41. Salbe AD, Kotler DP, Tierney AR, Wang J, Pierson RN, Campbell RG. Correlation between serum insulin-like growth factor-I (IGF-I) concentrations and nutritional status in HIV-infected individuals. Nutr Res 1995 ; 15 : 1437-43.
42. Lieberman SA, Butterfield GE, Harrison D, Hoffman AR. Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1994 ; 78 : 404-10.
43. Jacob V, Le Carpentier JE, Salzano S, Naylor V, Wild C, Brown CB et al. IGF-I, a marker of undernutrition in hemodialysis patients. Am J Clin Nutr 1990 ; 52 : 39-46.
44. Schaper NC. Growth hormone secretion in type 1 diabetes: a review. Acta Endocrinol (Copenhagen) 1990 ; 122 : 7-47.
45. Baxter RC, Martin JL. Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J Clin Invest 1986 ; 78 : 1504-12.
46. Batch JA, Baxter RC, Werther G. Abnormal regulation of insulin-like growth factor binding protein in adolescents with insulin-dependent diabetes. J Clin Endocrinol Metab 1991 ; 73 : 964-8.
47. Kratzsch J, Blum WF, Schenker E, Keller E. Regulation of growth hormone (GH), insulin-like growth factor (IGF-I), IGF binding proteins-1, -2, -3 and GH binding protein during progression of liver cirrhosis. Exp Clin Endocrinol 1995 ; 103 : 285-91.
48. Forbes GB, Brown MR, Welle SL, Underwood LE. Hormonal response to overfeeding. Am J Clin Nutr 1989 ; 49 : 608-11.
49. Underwood LE, Smith EP, Clemmons DR, Maes M, Maiter D, Ketelslegers JM. The production and actions of insulin-like growth factors: their relationship to nutrition and growth. In: Tanner JM editor. Auxology 88. London : Smith-Gordon, 1989 : 235-49.
50. Copeland KC, Colletti RB, Devlin JT, McAuliffe TL. The relationship between insulin-like growth factor-I, adiposity and aging. Metabolism 1990 ; 39 : 584-7.
51. Crist DM, Hill JM. Diet and insulin-like growth factor-I in relation to body composition in women with exercise-induced hypothalamic amenorrhea. J Am Coll Nutr 1990 ; 9 : 200-4.
52. Colletti RB, Copeland KC, Devlin JT, Roberts JD, McAuliffe TL. Effect of obesity on plasma insulin-like growth factor-I in cancer patients. Intl J Obesity 1991 ; 15 : 523-7.
53. Isley WL, Underwood LE, Clemmons DR. Changes in plasma somatomedin-C in response to ingestion of diets with variable protein and energy content. JPEN 1984 ; 8 : 407-11.
54. Snyder DK, Clemmons DR, Underwood LE. Dietary carbohydrate content determines responsiveness to growth hormone in energy-restricted humans. J Clin Endocrinol Metab 1989 ; 69 : 745-52.
55. Clemmons DR, Seek MM, Underwood LE. Supple-mental essential to non-essential amino acids aug-ment the somatomedin-C/insulin-like growth factor-1 response to refeeding after fasting. Metabolism 1985 ; 34 : 391-5.
56. Emler CA, Schalch DS. Nutritionally induced changes in hepatic insulin-like growth factor-1 gene expres-sion in rats. Endocrinology 1987 ; 120 : 832-4.
57. Thissen JP, Triest S, Moats-Staats BM, Underwood LE, Mauerhoff T, Maiter D et al. Evidence that pretranslational and translational defects decrease serum IGF-I concentrations during dietary proteins restriction. Endocrinology 1991 ; 129 : 429-35.
58. Suikkari AM, Sane T, Seppala M, Yki-Jarvinen H, Karonen SL, Koivisto VA. Prolonged exercise in-creases serum insulin-like growth-factor binding protein concentration. J Clin Endocrinol Metab. 1989 ; 68 : 141-4.
59. Smith AT, Clemmons DR, Underwood LE, Benn-Ezra V, McMurray R. The effect of exercise on plasma insulin-like growth factor-1 concentrations. Metabolism 1987 ; 36 : 533-7.
60. Moller S, Juul A, Becker U, Flyvbjerg A, Skakkebaek NE, Henriksen JH. Concentrations, release, and disposal of IGFBP, IGF-I, and growth hormone in different vascular beds in patients with cirrhosis. J Clin Endocrinal Metab 1995 ; 80 : 1148-57.
61. Lim VS, Kathpadia SC, Henriguez C. Endocrine abnormalities associated with chronic renal failure. Med Clin North Am 1978 ; 62 : 1341-4.
62. Lee PDK, Hintz RL, Sperry JB, Baxter RC, Powell DR. IGF binding proteins in growth retarded children with chronic renal failure. Pediatr Res 1989 ; 26 : 308-15.
63. Hill KK, Hill IB, McClain MP, Humphries LL, McClain CJ. Serum Insulin-like growth factor-1 concentrations in the recovery of patients with Anorexia Nervosa. J Am Coll Nutr 1993 ; 12 : 475-8.
64. Baxter RC, Bryson JM, Turtle JR. Somatogenic receptors of rat liver: regulations by insulin. Endocrinology 1980 ; 107 : 1176-81.
65. Phillips LS, Goldstein S, Pao CI. Nutrition and somatomedin. XXVI. Molecular regulation of IGF-I by insulin in cultured rat hepatocytes. Diabetes 1991 ; 40 : 1525-30.
66. Burnstein PJ, Draznin B, Johnson CJ, Schalch DS. The effect of hypothyroidism on growth, serum growth hormone, the growth-hormone dependent somatomedin, insulin-like growth factor, and its carrier protein in rat. Endocrinology 1979 ; 104 : 1107-11.
67. Borenfeldt KE, Arngvist HJ, Enberg B, Mathews LS, Norstedt G. Regulation of insulin-like growth factor-I and growth hormone receptor gene expression by diabetes and nutritional state in rat tissues. J Endocrinol 1989 ; 122 : 651-6.
68. Baxter RC. Insulin-like growth factor (IGF) binding proteins: the role of serum IGFBPs in regulating IGF availability. Acta Paediatr Scand (Suppl) 1991 ; 372 : 107-14.
69. McCusker RH, Camacho-Hubner C, Bayne ML. Insulin-like growth factor (IGF) binding to human fibroblasts and glioblastoma cells: The modulating effect of cell released IGF binding proteins (IGFBPs). J Cell Physiol 1990 ; 144 : 244-53.
70. Hossenlopp P, Segovia B, Lassarre C, Roghani M, Bredon M, Bionoux M. Evidence of enzymatic degradation of insulin-like growth factor-binding proteins is the 150 k complex during pregnancy. J Clin Endocrinol Metab 1990 ; 71 : 797-805.
71. Davies SC, Wass JAH, Ross RJM, Cotterill AM, Buchanan CR, Coulson VJ et al. The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. J Endocrinol 1991 ; 130 : 469-73.
72. Frost VJ, Macaulay VM, Wass JAH, Holly JMH. Proteolytic modification of insulin-like-growth factor-binding proteins: Comparison of conditioned media from human cell lines, circulating proteases and characterized enzymes. J Endocrinol 1993 ; 138 : 545-54.
73. Cwyfan Hughes SC, Cotterill AM, Molloy AR, Cassel TB, Braude N, Hinds CJ et al. The specific proteases for insulin-like growth factor-binding proteins following heart surgery. J Endocrinol 1992 ; 135 : 135-45.
74. Davenpont ML, Isley WL, Pucilowska JB, Pemberton LB, Lyman B, Underwood LE et al. Insulin-like growth factor-binding protein-3 proteolysis is induced following elective Surgery. J Clin Endocrinol Metab 1992 ; 75 : 590-5.
75. Bang P, Brismar K, Rosenfeld RG. Increased proteolysis of insulin-like growth factor-binding protein 3 (IGFBP3) in non-insulin dependent diabetes mellitus serum, with elevation of a 29 kDa glycosylated IGFBP-3 fragment contained in the approximately 130-150 kDa ternary complex. J Clin Endocrinol Metab 1994 ; 78 : 1119-27.
76. Grunfeld C, Feingold AR. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med 1992 ; 327 : 329-37.
77. Underwood LE, Thissen JP, Lemozy S, Ketelslegers JM, Clemmons DR. Hormonal and nutritional regulation of IGF-I and its binding proteins. Horm Res 1994 ; 42 : 145-51.
78. Kao PC, Laws ER, Zimmerman D. Somatomedin C/ insulin-like growth factor-I levels after treatment of acromegaly. Ann Clin Lab Sci 1992 ; 22 : 95-9.
79. Froesch ER, Hussain M. Metabolic effects of insulin-like growth factor-1 with special reference to diabetes. Acta Pediatr 1994 ; Suppl 399 : 165-70
80. Jeffries MK, Vance ML. Growth hormone and cortisol secretion in patients with brain injury. J Burn Care Rehabil 1992 ; 13 : 391-5.
81. Cioffi WG, Gore DC, Rue LW, Carrougher G, Guler HP, McManns W et al. Insulin-like growth factor-1 lowers protein oxidation in patients with thermal injury. Ann Surg 1994 ; 220 : 310-9.
82. Rossen CJ, Donahue LR, Hunter SJ. Insulin-like growth factors and Bone: The osteoporosis connection. Proc Soc Exp Biol Med 1994 ; 206 : 83-101.
83. Ramos-Dias JC, Yateman M, Camacho-Hubner C, Grossman A, Lengyel AJ. Low circulatory IGF-I levels in hyperthyroidism are associated with decreased GH response to GH-releasing hormone. Clin Endocrinol 1995 ; 43 : 583-9.